Optimizing Research Strategies
Song Biotechnologies, LLC is an innovative East Coast based in vivo Contract Research Organization (CRO). Our mission is to provide a full spectrum of solutions consisting of both standard and novel technologies that improve the performance and operational effectiveness of our clients and scientific collaborators. Our research focus is on in vivo cardiovascular and microcirculatory parameters; though we have ex vivo and in vitro capabilities as well.
Capabilities
Microscopy
Song Biotechnologies, LLC offers the highest level of intravital microcirculatory analysis through brightfield, fluorescence, and phosphorescence microscopy.
Biometrics
With a customizable platform, studies are tailored to pair primary metrics with real-time data outputs of animal hemodynamics, microcirculation, and biomarker sampling.
In Vivo
Established track record of designing and/or utilizing novel testable in vivo models to demonstrate safety, efficacy, mechanism of action, and highlight future directions.
Videos
Leukocyte Rolling
Rheological Reflux
Vasospasm
Testimonials
For well over a decade now, Song Biotechnologies has been an invaluable partner in our journey to bring Ox66®, our groundbreaking powdered oxygen product, to both the commercial and the medical world. As a premier in vivo Contract Research Organization (CRO), their expertise...
Leslie Peters
As the CEO of Chariot Biosciences, I am a fan of of Song Biotech, which stands out as the premier animal study CRO in the Mid-Atlantic region!!! The unwavering commitment to advancing cutting-edge technologies and therapies is evident in their approach to every...
Derese Getnet PhD, D(ABMM)
It has been my privilege and pleasure to have worked with and to be continuing to work with Dr Bjorn Song on multiple projects utilizing a novel topical/transdermal formulation. Studies have included : i)treatment of LPS induced vascular dysfunction; ii) prophylaxis and treatment...
Joel Friedman MD, PhD
Song Biotechnologies CRO services have been vital to our company for the past 10 years. They provided us responsive cardiovascular and microcirculatory expertise with advanced in vivo and in vitro analysis and associated peer reviewed publications of experimental data. Their results have been...
Brooks Bash
As the former CEO and CSO of Prolong Pharmaceuticals, I have been involved with many contract research organizations over the decades, and Song Biotechnologies stands out among them all. Their understanding of HBOCs in vivo is unparalleled, and their unique microcirculatory and tissue...
Abe Abuchowski, PhD
I am very pleased to offer my support for Bjorn Song and his colleagues at Song Biotechnologies. I have over 20 years of experience working with their group, and they have proven to be, in my opinion, leading Physiologists in small and large...
Kim D. Vandegriff, PhD
Interested in working with us or learning more?
Send us a message!